{"data":{"id":"us-or/ors-689.662","jurisdiction":"us-or","citation":"ORS 689.662","heading":"Authority to test and prescribe, dispense and administer treatment for COVID-19; rules.","body":"(1) Consistent with the protocols adopted by the State Board of Pharmacy by rule, as recommended by the Public Health and Pharmacy Formulary Advisory Committee, a pharmacist may test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prescribe, dispense and administer treatment, including drug therapy, for SARS-CoV-2.\n      (2) When testing for SARS-CoV-2, a pharmacist may use:\n      (a) A screening procedure that can be safely performed by a pharmacist; and\n      (b) A test that:\n      (A) Guides the pharmacist’s clinical decision-making;\n      (B) Is determined by the Centers for Medicare and Medicaid Services to qualify as a waived test under the Clinical Laboratory Improvement Amendments of 1988 (P.L. 100-578, 42 U.S.C. 201 and 263a) or federal regulations adopted pursuant to the Clinical Laboratory Improvement Amendments of 1988 or is approved by the United States Food and Drug Administration; and\n      (C) Is approved by the board by rule for use under this section.\n      (3) A pharmacist may delegate to a pharmacy technician or an intern under the pharmacist’s supervision the administrative and technical tasks of performing a task described in subsection (2) of this section.\n      (4) The board may adopt rules as necessary to carry out this section.","path":["17 - Occupations","52. Occupations and Professions","Chapter 689 — Pharmacists; Drug Outlets; Drug Sales"],"source_url":"https://www.oregonlegislature.gov/bills_laws/ors/ors689.html","current_through":"2025 Edition","vintage":"","retrieved_at":"2026-09-03T23:50:17Z","sha256":"677c505785eac49cd5713ca30872693112c4f9f6d761e699f5cc343e540cd563","source_id":"us-or","stale":false,"prev":"us-or/ors-689.661","next":"us-or/ors-689.665"},"notice":"GroundRules: Original legal text. Not legal advice."}